SCM
NVRO

Semanteon Capital Management’s NEVRO CORP. NVRO Stock Holding History

Semanteon Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,282
Closed -$885K – 332
2024
Q1 		$885K Buy
61,282
+9,136
+18% +$151K 0.57% 86
2023
Q4 		$1.12M Buy
+52,146
New +$930K 0.76% 57

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Semanteon Capital Management's NVRO Position: Q2 2024 in Review

Semanteon Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 61,282 shares — an estimated $885K sold.

Semanteon Capital Management first reported a position in NVRO in Q4 2023 and held it in 2 quarters. The position peaked at $1.12M in Q4 2023. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Semanteon Capital Management reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 61,282 NEVRO CORP. shares in Q2 2024, an estimated $885K.
  • Semanteon Capital Management first reported a position in NEVRO CORP. in Q4 2023 and held it in 2 quarters.
  • Semanteon Capital Management's NEVRO CORP. position peaked at $1.12M in Q4 2023.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Semanteon Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.